CVS Health (CVS) puts active on Amazon (AMZN) has agreed to acquire PillPack
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
CVS Health (CVS) PT Lowered to $84 at RBC Capital on Amazon Effect
June 29, 2018 7:10 AM EDTRBC Capital lowered its price target on CVS Health (NYSE: CVS) to $84.00 (from $91.00) while maintaining an Outperform rating to reflect Amazon's entrance into the pharmacy space.
"We acknowledge that Amazon has disrupted industries in the past, but believe that the stickiness of payer/ pharmacy... More
Buy CVS Health (CVS) and Express Scripts (ESRX) on Amazon/PillPack Deal Weakness - Mizuho
June 28, 2018 11:47 AM EDTMizuho analyst Ann Hynes said they would be buyers of CVS Health (NYSE: CVS) and Express Scripts (NASDAQ: ESRX) amid weakness related to Amazon's purchase of PillPack.
Hynes said the bark of the deal is likely worse than the bite, at lease initially. "Obviously from a multiple perspective, this announcement will weigh on valuation. From an earnings and cash flow perspective, that impact is less clear and our initial thoughts is market share gains will be limited, at least in the intermediate-term. We confirmed... More
